摘要
目的:探讨血清甘胆酸对肝硬化及原发性肝癌诊断的价值。方法:选择58例肝炎后肝硬化,18例原发性肝癌和26例无肝胆病史的对照组,用放免法测定血清甘胆酸(CG)含量。结果:肝硬化和肝癌组血清CG明显高于对照组,随肝硬化肝功能受损程度加重,CG逐渐增高(C>B>A级),而肝硬化和肝癌组CG无明显差异。肝硬化组ALT与CG比较,肝癌组CG与AFP比较,CG均明显较ALT及AFP更为敏感,阳性率更高。结论:CG是反应肝细胞损伤及肝病严重程度的敏感指标,对判断肝硬化的预后及原发性肝癌的诊断具有重要的参考价值。
Objective:To investigate the value of serum CG in diagnosing liver cirrhosis (L.C) and primary hepatocellular carcinoma (PHC).Mothods:By using RIA method,the serum contents of CG were detected from 58 LC,18 PHC patients and 26 controls.Results:The serum levets of CG in LC and PHC groups were much higher than those in controls.With the exacerbation of the hopatic function injured,CG lwels were graduately in creased (C>B>A class),but there was no significance difference between LC and PHC groups.CG was much more sensitive than ALT in LC group and AFP in PHC group,and its positive rate was much higher.Conclusions:CG was a sensitive indicator,reacting the exent of hepatocytes injured and liver disease devoloping. CG was also of help for the assessent of the prognosis of LC and the diagnosis of PHC.
出处
《山西临床医药》
1999年第2期88-89,共2页
Shanxi Clinical Medicine
关键词
肝硬化
原发性
肝癌
甘胆酸
诊断
Liver cilrhosis
Primary hopatocelluler carcinoma
CG